Source:http://linkedlifedata.com/resource/pubmed/id/15695060
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-2-7
|
pubmed:abstractText |
The aim of the present study was to assess vesicular monoamine transporter (VMAT2) density in attention deficit/hyperactivity disorder (ADHD), a disorder involving monoaminergic dysregulation. It was hypothesized that the hypoactivity of monoaminergic neurotransmission related to ADHD could be associated with an under-expression of VMAT2. We assessed high affinity [3H]dihydrotetrabenazine [TBZOH] binding to platelet VMAT2 in untreated male ADHD children and adolescents (n=11) as compared to age-matched controls (n=14), as well as the correlation between VMAT2 density and the severity of ADHD symptoms as measured by the clinician-administered DSM-IV ADHD Scale (DAS) and the parent-administered Abbreviated Conners' Rating Scale (ACPRS). The [3H]TBZOH binding capacity (Bmax) was significantly lower (17%) in the ADHD group as compared to the controls. There was no difference between the two groups in the affinity (Kd value) of [3H]TBZOH to its binding site. An inverse correlation was found between the ADHD symptom scales and the Bmax values. It remains unclear whether the under-expression of platelet VMAT2 in ADHD children is reflective of a parallel change in the brain, and whether it is primary or an epiphenomenon of ADHD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/SLC18A2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrabenazine,
http://linkedlifedata.com/resource/pubmed/chemical/Vesicular Biogenic Amine Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/Vesicular Monoamine Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/dihydrotetrabenazine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0924-977X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-62
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15695060-Adolescent,
pubmed-meshheading:15695060-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:15695060-Blood Platelets,
pubmed-meshheading:15695060-Child,
pubmed-meshheading:15695060-Gene Expression Regulation,
pubmed-meshheading:15695060-Humans,
pubmed-meshheading:15695060-Male,
pubmed-meshheading:15695060-Membrane Glycoproteins,
pubmed-meshheading:15695060-Membrane Transport Proteins,
pubmed-meshheading:15695060-Protein Binding,
pubmed-meshheading:15695060-Severity of Illness Index,
pubmed-meshheading:15695060-Tetrabenazine,
pubmed-meshheading:15695060-Vesicular Biogenic Amine Transport Proteins,
pubmed-meshheading:15695060-Vesicular Monoamine Transport Proteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.
|
pubmed:affiliation |
Tel-Aviv Community Mental Health Center and the Sackler Faculty of Medicine, Tel-Aviv University, Israel.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|